Translational Neuromodeling Unit, University of Zurich and Swiss Federal Institute of Technology in Zurich, Zurich, Switzerland.
Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
JAMA Psychiatry. 2020 May 1;77(5):513-522. doi: 10.1001/jamapsychiatry.2019.4971.
Nearly 1 in 3 patients with major depressive disorder who respond to antidepressants relapse within 6 months of treatment discontinuation. No predictors of relapse exist to guide clinical decision-making in this scenario.
To establish whether the decision to invest effort for rewards represents a persistent depression process after remission, predicts relapse after remission, and is affected by antidepressant discontinuation.
DESIGN, SETTING, AND PARTICIPANTS: This longitudinal randomized observational prognostic study in a Swiss and German university setting collected data from July 1, 2015, to January 31, 2019, from 66 healthy controls and 123 patients in remission from major depressive disorder in response to antidepressants prior to and after discontinuation. Study recruitment took place until January 2018.
Discontinuation of antidepressants.
Relapse during the 6 months after discontinuation. Choice and decision times on a task requiring participants to choose how much effort to exert for various amounts of reward and the mechanisms identified through parameters of a computational model.
A total of 123 patients (mean [SD] age, 34.5 [11.2] years; 94 women [76%]) and 66 healthy controls (mean [SD] age, 34.6 [11.0] years; 49 women [74%]) were recruited. In the main subsample, mean (SD) decision times were slower for patients (n = 74) compared with controls (n = 34) (1.77 [0.38] seconds vs 1.61 [0.37] seconds; Cohen d = 0.52; P = .02), particularly for those who later relapsed after discontinuation of antidepressants (n = 21) compared with those who did not relapse (n = 39) (1.95 [0.40] seconds vs 1.67 [0.34] seconds; Cohen d = 0.77; P < .001). This slower decision time predicted relapse (accuracy = 0.66; P = .007). Patients invested less effort than healthy controls for rewards (F1,98 = 33.970; P < .001). Computational modeling identified a mean (SD) deviation from standard drift-diffusion models that was more prominent for patients than controls (patients, 0.67 [1.56]; controls, -0.71 [1.93]; Cohen d = 0.82; P < .001). Patients also showed higher mean (SD) effort sensitivity than controls (patients, 0.31 [0.92]; controls, -0.08 [1.03]; Cohen d = 0.51; P = .05). Relapsers differed from nonrelapsers in terms of the evidence required to make a decision for the low-effort choice (mean [SD]: relapsers, 1.36 [0.35]; nonrelapsers, 1.17 [0.26]; Cohen d = 0.65; P = .02). Group differences generally did not reach significance in the smaller replication sample (27 patients and 21 controls), but decision time prediction models from the main sample generalized to the replication sample (validation accuracy = 0.71; P = .03).
This study found that the decision to invest effort was associated with prospective relapse risk after antidepressant discontinuation and may represent a persistent disease process in asymptomatic remitted major depressive disorder. Markers based on effort-related decision-making could potentially inform clinical decisions associated with antidepressant discontinuation.
近三分之一的抗抑郁药治疗有效后停药 6 个月内复发的重度抑郁症患者会复发。目前还没有预测复发的指标来指导这种情况下的临床决策。
确定在缓解期后,为获得奖励而付出努力的决策是否代表一种持续的抑郁过程,是否可以预测缓解后的复发,以及是否受到抗抑郁药停药的影响。
设计、地点和参与者:这项在瑞士和德国大学环境中进行的纵向随机观察性预后研究,从 2015 年 7 月 1 日至 2019 年 1 月 31 日,共从 66 名健康对照者和 123 名在抗抑郁药治疗后缓解的重度抑郁症患者中收集数据。招募工作于 2018 年 1 月前完成。
抗抑郁药停药。
停药后 6 个月内的复发。需要参与者选择为不同数量的奖励付出多少努力的任务的选择和决策时间,以及通过计算模型的参数确定的机制。
共招募了 123 名患者(平均[标准差]年龄,34.5[11.2]岁;94 名女性[76%])和 66 名健康对照者(平均[标准差]年龄,34.6[11.0]岁;49 名女性[74%])。在主要子样本中,与对照组(n=34)相比,患者(n=74)的决策时间较慢(1.77[0.38]秒比 1.61[0.37]秒;Cohen d=0.52;P=0.02),特别是对于那些停药后复发的患者(n=21)与那些未复发的患者(n=39)相比(1.95[0.40]秒比 1.67[0.34]秒;Cohen d=0.77;P<.001)。较慢的决策时间可以预测复发(准确性=0.66;P=0.007)。患者为奖励付出的努力比健康对照者少(F1,98=33.970;P<.001)。计算模型确定了一种偏离标准漂移-扩散模型的平均值(标准差),这种偏离在患者中比在对照组中更为明显(患者,0.67[1.56];对照组,-0.71[1.93];Cohen d=0.82;P<.001)。患者的努力敏感度也高于对照组(患者,0.31[0.92];对照组,-0.08[1.03];Cohen d=0.51;P=0.05)。在需要做出低努力选择的决策时,复发者与非复发者所需的证据存在差异(平均值[标准差]:复发者,1.36[0.35];非复发者,1.17[0.26];Cohen d=0.65;P=0.02)。在较小的复制样本(27 名患者和 21 名对照者)中,组间差异通常没有达到显著水平,但来自主样本的决策时间预测模型在复制样本中得到了推广(验证准确性=0.71;P=0.03)。
这项研究发现,为获得奖励而付出努力的决策与抗抑郁药停药后复发的风险相关,并且可能代表了无症状缓解期重度抑郁症的持续疾病过程。基于努力相关决策的标志物可能有潜力为与抗抑郁药停药相关的临床决策提供信息。